Free Trial

Ayala Pharmaceuticals (ADXS) News Today

$0.25
+0.04 (+19.05%)
(As of 05/24/2024 ET)
Immunome: An Oncology Powerhouse In The Making
IMNM Oct 2024 22.500 call
IMNM Oct 2024 25.000 call
IMNM Oct 2024 25.000 put
IMNM Oct 2024 45.000 call
Ayala Pharmaceuticals Inc Ordinary Shares ADXS
Ayala Pharmaceuticals Inc (ADXS)
Armando Ayala
Ayala Pharmaceuticals, Inc. (ADXS)
Hubei Biocause Pharmaceutical
Advaxis and Ayala Pharmaceuticals Complete Merger
Form 8-K Advaxis, Inc. For: Oct 18 - StreetInsider.com
Ayala, Advaxis Merge - Baystreet.ca
Get Ayala Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for ADXS and its competitors with MarketBeat's FREE daily newsletter.

The only AI company to buy (Ad)

The AI boom is just getting started. And the real wealth has still to be made…

You must read this new presentation from Porter Stansberry.

ADXS Media Mentions By Week

ADXS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ADXS
News Sentiment

0.00

0.76

Average
Medical
News Sentiment

ADXS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ADXS Articles
This Week

0

0

ADXS Articles
Average Week

Get Ayala Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for ADXS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:ADXS) was last updated on 5/25/2024 by MarketBeat.com Staff

From Our Partners